EA201300540A1 - Способ лечения, облегчения и/или предупреждения колоректального рака - Google Patents

Способ лечения, облегчения и/или предупреждения колоректального рака

Info

Publication number
EA201300540A1
EA201300540A1 EA201300540A EA201300540A EA201300540A1 EA 201300540 A1 EA201300540 A1 EA 201300540A1 EA 201300540 A EA201300540 A EA 201300540A EA 201300540 A EA201300540 A EA 201300540A EA 201300540 A1 EA201300540 A1 EA 201300540A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
colorectal cancer
relief
peg
Prior art date
Application number
EA201300540A
Other languages
English (en)
Russian (ru)
Inventor
Коринне Де Врис
Лейтон Джонс
Иэн Кокс
Йорг Плессль
Сэмюель Смит
Питер Стейн
Речел Чарлтон
Original Assignee
Норджин Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Норджин Бв filed Critical Норджин Бв
Publication of EA201300540A1 publication Critical patent/EA201300540A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
EA201300540A 2010-11-04 2011-11-04 Способ лечения, облегчения и/или предупреждения колоректального рака EA201300540A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
EA201300540A1 true EA201300540A1 (ru) 2013-09-30

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300540A EA201300540A1 (ru) 2010-11-04 2011-11-04 Способ лечения, облегчения и/или предупреждения колоректального рака

Country Status (22)

Country Link
US (2) US20130216493A1 (https=)
EP (1) EP2635289B1 (https=)
JP (1) JP5917537B2 (https=)
KR (1) KR20130109171A (https=)
CN (1) CN103313719A (https=)
AR (1) AR083770A1 (https=)
AU (1) AU2011324996B2 (https=)
BE (1) BE1019494A3 (https=)
BR (1) BR112013011012A2 (https=)
CA (1) CA2816839A1 (https=)
EA (1) EA201300540A1 (https=)
ES (1) ES2401269B1 (https=)
GB (1) GB201018650D0 (https=)
MX (1) MX349690B (https=)
MY (1) MY163067A (https=)
NL (1) NL2007715C2 (https=)
NZ (1) NZ611145A (https=)
SG (1) SG189533A1 (https=)
TW (1) TWI606832B (https=)
UA (1) UA107998C2 (https=)
WO (1) WO2012059725A1 (https=)
ZA (1) ZA201304052B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
MX382868B (es) 2012-09-11 2025-03-13 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
EP3934661B1 (en) 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers
WO2020180555A1 (en) * 2019-03-05 2020-09-10 Dow Global Technologies Llc Polyethyleneglycol derivatives for inducing caspase activity
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
BE1019494A3 (fr) 2012-07-03
NL2007715A (en) 2012-05-07
MX349690B (es) 2017-08-09
AU2011324996A1 (en) 2013-05-02
GB201018650D0 (en) 2010-12-22
MY163067A (en) 2017-08-15
TW201304785A (zh) 2013-02-01
WO2012059725A1 (en) 2012-05-10
US20160228467A1 (en) 2016-08-11
MX2013004963A (es) 2013-08-27
NZ611145A (en) 2015-07-31
EP2635289B1 (en) 2020-03-11
KR20130109171A (ko) 2013-10-07
ES2401269B1 (es) 2014-02-19
AU2011324996B2 (en) 2015-10-08
WO2012059725A8 (en) 2013-05-30
TWI606832B (zh) 2017-12-01
UA107998C2 (uk) 2015-03-10
CA2816839A1 (en) 2012-05-10
ES2401269A1 (es) 2013-04-18
BR112013011012A2 (pt) 2016-08-23
CN103313719A (zh) 2013-09-18
NL2007715C2 (en) 2012-10-16
EP2635289A1 (en) 2013-09-11
JP2013544809A (ja) 2013-12-19
ZA201304052B (en) 2014-02-26
AR083770A1 (es) 2013-03-20
JP5917537B2 (ja) 2016-05-18
SG189533A1 (en) 2013-05-31
US20130216493A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
EA201300540A1 (ru) Способ лечения, облегчения и/или предупреждения колоректального рака
NZ729643A (en) Combination therapy for treating cancer
PH12012502380B1 (en) Methods of treatment of pancreatic cancer
EA201290356A1 (ru) Композиции для лечения тошноты и рвоты центрального происхождения
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
WO2017096309A8 (en) Methods of treatment of malignancies
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201390144A1 (ru) Конъюгаты терапевтический пептид-полимер, частицы, композиции и связанные с ними способы
WO2012170807A3 (en) Anti-pseudomonas psl binding molecules and uses thereof
NZ599507A (en) Pyrazole derivatives as modulators of calcium release -activated calcium channel
WO2017079570A3 (en) Splise-switching oligonucleotides and methods of use
MY166014A (en) Combination therapy methods for treating proliferative diseases
WO2010132697A3 (en) Methods and compositions for treatment
MX2013012387A (es) Composicion que comprende aflibercept, acido folinico, 5-fluorouracilo (5-fu) e irinocetan (folfiri).
EA201590703A1 (ru) Ингибиторы mek при лечении вирусных заболеваний
PH12019501945B1 (en) Composition and method for preventing or delaying onset of myopia comprising atropine
MX391136B (es) FRAGMENTOS DE OspA ESTABILIZADOS CON CISTEÍNA Y MÉTODO DE USO
WO2011123678A3 (en) Substituted benzo-pyrido-triazolo-diazepine compounds
EA201492187A1 (ru) Способы лечения солидных опухолей с использованием кофермента q10
MX2016000131A (es) Nanoparticulas polimericas de docetaxel para el tratamiento de cancer.
WO2010032011A3 (en) Anti-fungal therapy
BR112012006468A2 (pt) métodos de tratamento de inflamação
MX2012013875A (es) Anticuerpos de union sparc en sangre periferica y usos de los mismos.
WO2013106460A3 (en) Compositions and methods for treating malignant astrocytomas